Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Akebia Therapeutics, Inc. (AKBA)  
$1.13 0.02 (1.74%) as of 4:30 Tue 5/21


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 144,540,000
Market Cap: 163.33(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8 - $2.24
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 179,485 250,285 435,949 785,921
Total Sell Value $264,737 $383,681 $608,761 $932,606
Total People Sold 4 4 4 6
Total Sell Transactions 10 12 15 29
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 264
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2024-05-13 4 AS $1.26 $43,898 D/D (34,840) 672,092 -11%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2024-05-13 4 AS $1.26 $15,140 D/D (12,016) 651,243 -11%     
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2024-02-29 4 S $1.58 $11,327 D/D (7,169) 695,840 28%     
   Butler John P. CEO and President   •       •      –    2024-02-29 4 S $1.58 $73,581 D/D (46,570) 2,044,580 28%     
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2024-02-29 4 S $1.58 $13,684 D/D (8,661) 706,932 28%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2024-02-29 4 S $1.58 $9,439 D/D (5,974) 663,259 28%     
   Butler John P. CEO and President   •       •      –    2024-02-27 4 S $1.52 $57,354 D/D (37,733) 2,091,150 31%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2024-02-27 4 AS $1.52 $11,265 D/D (7,411) 669,233 -30%     
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2024-02-27 4 AS $1.52 $12,718 D/D (8,367) 703,009 -30%     
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2024-02-27 4 S $1.52 $16,331 D/D (10,744) 715,593 31%     
   Butler John P. CEO and President   •       •      –    2024-02-01 4 S $1.68 $78,102 D/D (46,489) 2,128,883 34%     
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2024-02-01 4 S $1.68 $40,842 D/D (24,311) 711,376 34%     
   Butler John P. CEO and President   •       •      –    2024-01-31 4 A $0.00 $0 D/D 603,500 2,175,372     -
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 202,200 735,687     -
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 149,300 726,337     -
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 149,300 676,644     -
   Malabre Richard C Chief Accounting Officer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 223,950 223,950     -
   Grund Nicholas Chief Commercial Officer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 303,300 303,300     -
   Snow Ellen SVP, CFO and Treasurer   •       –      –    2024-01-31 4 A $0.00 $0 D/D 149,300 519,300     -
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2023-08-25 4 S $1.15 $31,050 D/D (27,000) 668,840 -32%     
   Snow Ellen SVP, CFO and Treasurer   •       –      –    2023-07-31 4 A $0.00 $0 D/D 370,000 370,000     -
   Gilman Steven C   –       •      –    2023-06-06 4 A $0.00 $0 D/D 30,000 87,130     -
   Wolf Myles   –       •      –    2023-06-06 4 A $0.00 $0 D/D 30,000 67,681     -
   Smith Cynthia   –       •      –    2023-06-06 4 A $0.00 $0 D/D 30,000 95,233     -
   Rogers Michael W   –       •      –    2023-06-06 4 A $0.00 $0 D/D 30,000 96,029     -
  264 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us